Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,170.00
Bid: 1,167.00
Ask: 1,169.00
Change: 20.00 (1.74%)
Spread: 2.00 (0.171%)
Open: 1,148.00
High: 1,174.00
Low: 1,144.00
Prev. Close: 1,150.00
HSX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hiscox appoints Jonathan Bloomer Chair designate

30 May 2023 07:00

RNS Number : 8926A
Hiscox Ltd
30 May 2023
 

 

 

 

 

 

Hiscox appoints Jonathan Bloomer as Chair designate

Hamilton, Bermuda (30 May 2023) - Hiscox Ltd (LSE:HSX), the international specialist insurer, today announces the appointment of Jonathan Bloomer as Chair designate, subject to regulatory approval. Jonathan will join the Board as Chair designate on 1 June 2023, succeeding Robert Childs who will retire on 1 July 2023.

Jonathan has a wealth of experience leading financial services organisations. He was a Partner at Arthur Andersen before joining Prudential plc in 1995, initially as CFO and then taking the role of CEO from 2000 to 2005. His final executive role was as an Operating Partner at Cerberus. A seasoned board director, Jonathan is currently serving as Chair of Morgan Stanley International, DWF Group plc and SDL Group Holdings Limited.

Colin Keogh, Hiscox Senior Independent Director, said: "After an extensive search I am delighted to have led the process that resulted in the Nominations and Governance Committee selecting Jonathan as the Board's next Chair. We will benefit from his experience and leadership and we are all very much looking forward to working with him.

 

"I would also like to take this opportunity to thank Rob once again for the immense contributions he has made during his long and distinguished career, not only to Hiscox but to the wider industry. He has navigated many insurance cycles, mentored many underwriters and leaves a legacy of integrity and strong results. We wish him all the best for the future." 

Rob Childs said: "The Board has made an outstanding choice in Jonathan Bloomer to be the next Chair of Hiscox. He joins the Group at an exciting time, with a range of opportunities ahead for continued profitable growth."

 

Aki Hussain, Hiscox Group CEO, said: "I am very much looking forward to working with Jonathan. His deep experience in driving international growth and managing complexity across a range of financial services companies and other businesses will be extremely valuable to us."

Jonathan Bloomer, Hiscox Chair designate, said: "I am delighted to be joining Hiscox, it is a great company, with a distinctive culture and an exciting future. I look forward to being part of the team."

There are no other details that are required to be disclosed in respect of the appointment of Jonathan Bloomer under Listing Rule 9.6.13.

-ENDS-

Notes to editors:

Jonathan Bloomer became a partner at Arthur Andersen before going on to become CFO and then CEO of FTSE 100 Prudential plc. Following this, he was an operating partner at Cerberus Capital Management, the US private equity and alternative investor, which he held between 2006 and 2012. Since 2012 Jonathan has pursued a successful portfolio career, with a range of largely financial services companies. He is currently Chair of Morgan Stanley International, DWF Group PLC (an international legal and business services company) and SDL Group Limited (a property services company). Previous board roles include chair of Arrow Global Group PLC (European investor and asset manager in non-performing and non-core assets) and senior independent director at Hargreaves Lansdown plc.

For further information:

Hiscox Ltd

Investors and analysts

Marc Wetherhill, Group Company Secretary +1 441 278 8300

Yana O'Sullivan, Group Head of Investor Relations, London +44 (0)20 3321 5598

Media

Carmel McCarthy, Group Communications, London +44 (0)7769 280903

Tom Burns/Simone Selzer, Brunswick Group +44(0) 207 404 5959

 

About the Hiscox Group

Hiscox is a global specialist insurer, headquartered in Bermuda and listed on the London Stock Exchange (LSE:HSX). Our ambition is to be a respected specialist insurer with a diverse portfolio by product and geography. We believe that building balance between catastrophe-exposed business and less volatile local specialty business gives us opportunities for profitable growth throughout the insurance cycle. 

The Hiscox Group employs over 3,000 people in 14 countries, and has customers worldwide. Through the retail businesses in the UK, Europe, Asia and the USA, we offer a range of specialist insurance for professionals and business customers as well as homeowners. Internationally traded, bigger ticket business and reinsurance is underwritten through Hiscox London Market and Hiscox Re & ILS.Our values define our business, with a focus on people, courage, ownership and integrity. We pride ourselves on being true to our word and our award-winning claims service is testament to that. 

For more information, visit www.hiscoxgroup.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUAAAUPWGPB
Date   Source Headline
1st Feb 20234:55 pmRNSTotal Voting Rights
16th Jan 20233:13 pmRNSDirector/PDMR Shareholding
13th Jan 20236:12 pmRNSAveva Group
7th Dec 20222:21 pmRNSDirector/PDMR Shareholding
1st Dec 202212:45 pmRNSTotal Voting Rights
28th Nov 20227:00 amRNSDirector PDMR Shareholding
14th Nov 202211:08 amRNSSyndicates 33 and 6104 – results and estimates
2nd Nov 20227:00 amRNSQ3 2022 Trading Statement
1st Nov 20224:19 pmRNSTotal Voting Rights
3rd Oct 20225:06 pmRNSTotal Voting Rights
26th Sep 20224:09 pmRNSDirector/PDMR Shareholding
22nd Sep 202211:00 amRNSDirector/PDMR Shareholding
15th Sep 20222:13 pmRNSApplication to be Admitted to the Official List
7th Sep 202212:04 pmRNSAnnouncement of the Scrip Reference Share price
6th Sep 20225:10 pmRNSDirector/PDMR Shareholding
1st Sep 20222:04 pmRNSTotal Voting Rights
12th Aug 20221:38 pmRNSDirector PDMR Shareholding
10th Aug 202212:29 pmRNSSyndicate Results
9th Aug 202211:05 amRNSDirector/PDMR Shareholding
3rd Aug 20227:00 amRNSInterim Report
6th Jul 202211:35 amRNSTotal Voting Rights
15th Jun 20222:05 pmRNSDirector/PDMR Shareholding
9th Jun 20221:09 pmRNSApplication to be Admitted to the Official List
31st May 20223:29 pmRNSAnnouncement of Scrip Reference Share Price
17th May 20225:30 pmRNSDirector/PDMR Shareholding
13th May 20223:30 pmRNSAppointment of Paul Cooper
13th May 20223:15 pmRNSAGM Results
10th May 202210:38 amRNSSyndicates 33 and 6104 – results and estimates
5th May 20227:00 amRNSTrading Statement
3rd May 202212:27 pmRNSTotal Voting Rights
21st Apr 20221:32 pmRNSTR-1 Standard form-notification major shareholding
11th Apr 20224:45 pmRNSNotice of 2022 Annual General Meeting
11th Apr 20222:43 pmRNSDirector/PDMR Shareholding
7th Apr 202211:07 amRNSDirector/PDMR Shareholding
1st Apr 202212:29 pmRNSTotal Voting Rights
29th Mar 20224:47 pmRNSDirector PDMR Shareholding
11th Mar 20224:27 pmRNS2021 Annual Report and Accounts
7th Mar 20226:10 pmRNSDirector/PDMR Shareholding
4th Mar 202210:55 amRNSSyndicates 33 and 6104 – results and estimates
2nd Mar 20227:00 amRNSFull Year Results
1st Mar 202212:15 pmRNSTotal Voting Rights
2nd Feb 20227:42 amRNSTR-1 Standard Form-Notification Major Shareholding
1st Feb 20225:03 pmRNSDirector/PDMR Shareholding
1st Feb 20225:03 pmRNSTotal Voting Rights
4th Jan 20227:00 amRNSTotal Voting Rights
21st Dec 20217:00 amRNSAppointment of Group Chief Financial Officer
13th Dec 20215:54 pmRNSDirector/PDMR Shareholding
6th Dec 20214:20 pmRNSTR-1:Standard form-notification major shareholding
1st Dec 20212:55 pmRNSTotal Voting Rights
22nd Nov 20219:00 amRNSHiscox appoints new Independent Non Exec Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.